Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-07

Clinical Trial Update: Liposomal Bupivacaine in Ambulatory Hand Surgery [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of liposomal bupivacaine in ambulatory hand surgery was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: Loma Linda University | Conditions: Pain | Phase 3 | Status: WITHDRAWN